Recovery From Malignant Hypertension With Anuria After Prolonged Hemodialysis

Autor: Barcenas Cg, Eigenbrodt E, Long Dl, Hull Ar

Publikováno v: Southern Medical Journal. 69:1230-1233

A 29-year-old black woman with malignant hypertension and anuria was treated with hemodialysis and antihypertensive drugs. Her renal function improved and her creatinine clearance was 28 ml/min after 4 1/2 months of treatment. Similar cases in the li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3be98526adad354dc888c95c0bb348
https://doi.org/10.1097/00007611-197609000-00039

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function.

Autor: Falcão-Pires I; UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Ferreira AF; UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Trindade F; UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Bertrand L; Université Catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Pôle of Cardiovascular Research, Brussels, Belgium.; WELBIO, Department, WEL Research Institute, Wavre, Belgium., Ciccarelli M; Cardiovascular Research Unit, Department of Medicine and Surgery, University of Salerno, Baronissi, Italy., Visco V; Cardiovascular Research Unit, Department of Medicine and Surgery, University of Salerno, Baronissi, Italy., Dawson D; Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK., Hamdani N; Department of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, Bochum, Germany.; Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology, Ruhr University Bochum, Bochum, Germany.; HCEMM-SU Cardiovascular Comorbidities Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; Department of Physiology, Cardiovascular Research Institute Maastricht University Maastricht, Maastricht, the Netherlands., Van Laake LW; Division Heart and Lungs, Department of Cardiology and Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, The Netherlands., Lezoualc'h F; Institut des Maladies Métaboliques et Cardiovasculaires, Inserm, Université Paul Sabatier, UMR 1297-I2MC, Toulouse, France., Linke WA; Institute of Physiology II, University Hospital Münster, Münster, Germany., Lunde IG; Oslo Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevaal, Oslo, Norway.; KG Jebsen Center for Cardiac Biomarkers, Campus Ahus, University of Oslo, Oslo, Norway., Rainer PP; Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; BioTechMed Graz, Graz, Austria.; St. Johann in Tirol General Hospital, St. Johann in Tirol, Austria., Abdellatif M; Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; BioTechMed Graz, Graz, Austria., Van der Velden J; Department of Physiology, Amsterdam UMC, Amsterdam, The Netherlands., Cosentino N; Centro Cardiologico Monzino IRCCS, Milan, Italy.; Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Paldino A; Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Pompilio G; Centro Cardiologico Monzino IRCCS, Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Zacchigna S; Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Heymans S; Department of Cardiology, CARIM Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.; Centre of Cardiovascular Research, University of Leuven, Leuven, Belgium., Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany., Tocchetti CG; Department of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Jul; Vol. 26 (7), pp. 1454-1479. Date of Electronic Publication: 2024 Jun 04.

Metabolic alkalosis after massive blood transfusion. Correction by hemodialysis.

Autor: Barcenas CG, Fuller TJ, Knochel JP

Publikováno v: JAMA [JAMA] 1976 Aug 23; Vol. 236 (8), pp. 953-4.

CARDIOGENIC ACUTE RENAL FAILURE (CARF) FOLLOWING OPEN-HEART SURGERY.

Autor: Barcenas CG; Nephrology, Department of Medicine, and the Cardiovascular Surgery Department of St. Luke's Episcopal Hospital and the Texas Heart Institute, Houston, Texas., Jones P, Solomon S, Van Reet R, Cooley DA

Publikováno v: Cardiovascular diseases [Cardiovasc Dis] 1979 Sep; Vol. 6 (3), pp. 298-307.